Search research articles
Contact Us
Filters
Showing results (191-200 of 219) with videos related to
Page
of 22
Sort By:
Gut
|
July 8, 2005
Genetic basis for increased intestinal permeability in families with Crohn's disease: role of CARD15 3020insC mutation?
S Buhner, C Buning, J Genschel, et al.
Gastroenterology
|
October 1, 1991
Comparison of enteral nutrition and drug treatment in active Crohn's disease. Results of the European Cooperative Crohn's Disease Study. IV
H Lochs, H J Steinhardt, B Klaus-Wentz, et al.
Scandinavian Journal of Gastroenterology
|
June 11, 2003
The C/C(-13910) and G/G(-22018) genotypes for adult-type hypolactasia are not associated with inflammatory bowel disease
C Büning, J Ockenga, S Krüger, et al.
The American Journal of Gastroenterology
|
August 13, 1999
Clinical relevance of serum interleukin-6 in Crohn's disease: single point measurements, therapy monitoring, and prediction of clinical relapse
W Reinisch, C Gasché, W Tillinger, et al.
Scandinavian Journal of Gastroenterology
|
April 27, 2017
The C/C_₁₃₉₁₀ and G/G_₂₂₀₁₈ Genotypes for Adult-type Hypolactasia are not Associated with Inflammatory Bowel Disease
C Büning, J Ockenga, S Krüger, et al.
Alimentary Pharmacology & Therapeutics
|
May 15, 2004
Mutations in the NOD2/CARD15 gene in Crohn's disease are associated with ileocecal resection and are a risk factor for reoperation
C Büning, J Genschel, S Bühner, et al.
International Journal of Colorectal Disease
|
May 3, 2005
n-3, n-6, and n-9 polyunsaturated fatty acids--which composition in parenteral nutrition decreases severity of acute hemorrhagic necrotizing pancreatitis in rats?
M Kilian, I Heukamp, J I Gregor, et al.
European Journal of Endocrinology
|
February 3, 2006
Elevated transaminases during medical treatment of acromegaly: a review of the German pegvisomant surveillance experience and a report of a patient with histologically proven chronic mild active hepatitis
H Biering, B Saller, J Bauditz, et al.
The Journal of Clinical Endocrinology and Metabolism
|
May 10, 2001
Dyslipemia in familial partial lipodystrophy caused by an R482W mutation in the LMNA gene
H H Schmidt, J Genschel, P Baier, et al.
European Journal of Gastroenterology & Hepatology
|
September 1, 1996
Oral pH-modified release budesonide versus 6-methylprednisolone in active Crohn's disease. German/Austrian Budesonide Study Group
V Gross, T Andus, I Caesar, et al.
Page
of 22
Search research articles
Search
Showing results (191-200 of 219) with videos related to
Sort By:
Page
of 22
Gut
|
July 8, 2005
Genetic basis for increased intestinal permeability in families with Crohn's disease: role of CARD15 3020insC mutation?
S Buhner, C Buning, J Genschel, et al.
Gastroenterology
|
October 1, 1991
Comparison of enteral nutrition and drug treatment in active Crohn's disease. Results of the European Cooperative Crohn's Disease Study. IV
H Lochs, H J Steinhardt, B Klaus-Wentz, et al.
Scandinavian Journal of Gastroenterology
|
June 11, 2003
The C/C(-13910) and G/G(-22018) genotypes for adult-type hypolactasia are not associated with inflammatory bowel disease
C Büning, J Ockenga, S Krüger, et al.
The American Journal of Gastroenterology
|
August 13, 1999
Clinical relevance of serum interleukin-6 in Crohn's disease: single point measurements, therapy monitoring, and prediction of clinical relapse
W Reinisch, C Gasché, W Tillinger, et al.
Scandinavian Journal of Gastroenterology
|
April 27, 2017
The C/C_₁₃₉₁₀ and G/G_₂₂₀₁₈ Genotypes for Adult-type Hypolactasia are not Associated with Inflammatory Bowel Disease
C Büning, J Ockenga, S Krüger, et al.
Alimentary Pharmacology & Therapeutics
|
May 15, 2004
Mutations in the NOD2/CARD15 gene in Crohn's disease are associated with ileocecal resection and are a risk factor for reoperation
C Büning, J Genschel, S Bühner, et al.
International Journal of Colorectal Disease
|
May 3, 2005
n-3, n-6, and n-9 polyunsaturated fatty acids--which composition in parenteral nutrition decreases severity of acute hemorrhagic necrotizing pancreatitis in rats?
M Kilian, I Heukamp, J I Gregor, et al.
European Journal of Endocrinology
|
February 3, 2006
Elevated transaminases during medical treatment of acromegaly: a review of the German pegvisomant surveillance experience and a report of a patient with histologically proven chronic mild active hepatitis
H Biering, B Saller, J Bauditz, et al.
The Journal of Clinical Endocrinology and Metabolism
|
May 10, 2001
Dyslipemia in familial partial lipodystrophy caused by an R482W mutation in the LMNA gene
H H Schmidt, J Genschel, P Baier, et al.
European Journal of Gastroenterology & Hepatology
|
September 1, 1996
Oral pH-modified release budesonide versus 6-methylprednisolone in active Crohn's disease. German/Austrian Budesonide Study Group
V Gross, T Andus, I Caesar, et al.
Page
of 22